Healthcare Practices
For more on the Preeclampsia Foundation's work to amplify all research related to biomarkers for improved prediction and diagnostic tools, please visit https://preeclampsia.org/biomarkers. INDIANAPOLIS, Feb. 13, 2025 /PRNewswire/ -- Roche announced...
"GAP—SPIRIN" is an evidence-based education campaign, encouraging the use of low-dose aspirin to help prevent preeclampsia and close the maternal health equity gap.
1732072344.png)
Strategic Roadmap to Address High Rates of Hypertension-related Maternal Mortality and Morbidity in Black Women
Washington, DC – April 11, 2024 – On April 10, one day before the start of Black Maternal Health Week, the Preeclampsia Foundation in partnership with Thermo Fisher Diagnostics held a Hill Briefing – “Putting Pressure on Mater...
Advocate Shakima Tozay discusses the Black maternal health crisis and how we can improve outcomes for BIWOC patients with preeclampsia.
The Preeclampsia Foundation announced today that the Centers for Disease Control and Prevention (CDC) awarded new funding for its MoMMAs Voices program, a national coalition of patient advocacy organizations and individuals with "lived experience" –...
The U.S. Preventive Services Task Force (USPSTF) released today a final recommendation statement on screening for hypertensive disorders of pregnancy. The Task Force recommends that all pregnant people have their blood pressure measured throughout pr...
Abt Associates, together with subcontractors HealthBegins and the MoMMAs Voices program of the Preeclampsia Foundation, will provide technical assistance and evaluation support to 36 HRSA-supported health centers who are implementing innovative appro...
Recommendations for high-risk expecting parents and health care providers to promote the prevention of preeclampsia, a leading cause of pregnancy-related death in the United States.
Education Manager Maggie Barker recaps the 2022 Alliance for Innovation in Maternal Health Conference.
The Preeclampsia Foundation announced that its Cuff Kit® program is a Phase 1 winner of the U.S. Department of Health and Human Services (HHS) Office on Women’s Health (OWH) Hypertension Innovator Award Competition.
Preeclampsia puts women at increased risk for heart disease as well as stroke and high blood pressure later in life. Large population studies have demonstrated that two of three preeclampsia survivors will die of heart disease. That’s news to m...